🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a multi-center Phase II randomized study. We plan to enroll 78 pati...
Status
Terminated
Location
City of Hope
Start Date
2018-06-26
Trial ID
NCT03547999
Treatments Being Tested
Nivolumab releases the inhibition of the immune system against human cancer...
Status
Terminated
Location
Rhode Island Hospital
Start Date
2016-02
Trial ID
NCT02469701
Treatments Being Tested
The inhibition of programmed cell death protein 1 (PD-1) has shown promisin...
Status
Completed
Location
Sun Yat-sen University Cancer Center
Start Date
2019-06-01
Trial ID
NCT03939975
Treatments Being Tested
This study will investigate if nivolumab will improve recurrence-free survi...
Status
Active Not Recruiting
Location
Local Institution - 0081
Start Date
2018-04-18
Trial ID
NCT03383458
Clearing potential intrahepatic metastasis to prevent early recurrence afte...
Status
Completed
Location
Wanfang Hospital
Start Date
2019-10-16
Trial ID
NCT04707547
Treatments Being Tested
This study seeks to estimate the occurrence of adverse events related to th...
Status
Completed
Location
Antelope Valley Urology & Incontinence
Start Date
2019-06-28
Trial ID
NCT04090775
Treatments Being Tested
A prospective, single-arm, non-randomized, multi-center, open-label study f...
Status
Terminated
Location
Mayo Clinic Rochester
Start Date
2023-02-01
Trial ID
NCT05583188
The is a phase II, single arm, open-label, multi-site trial studying the co...
Status
Completed
Location
Children's National Hospital
Start Date
2022-02-18
Trial ID
NCT05302921
Treatments Being Tested
The purpose of this Phase 2 study is to 1. find out if the study drugs (ip...
Status
Completed
Location
Stanford Medical Center
Start Date
2019-10-01
Trial ID
NCT04118166
Treatments Being Tested
The goal of this clinical trial is to evaluate the efficacy and safety of r...
Status
Recruiting
Location
Fudan University Shanghai Cancer Center
Start Date
2023-01-01
Trial ID
NCT06121700